Aura Biosciences Q3 EPS $(0.48) Beats $(0.52) Estimate
Portfolio Pulse from Benzinga Newsdesk
Aura Biosciences (NASDAQ:AURA) reported Q3 losses of $(0.48) per share, beating the analyst consensus estimate of $(0.52) by 7.69 percent. This represents an 11.11 percent increase over losses of $(0.54) per share from the same period last year.
November 09, 2023 | 10:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aura Biosciences reported better than expected Q3 losses, which could positively impact the stock in the short term.
Aura Biosciences reported a smaller loss than expected for Q3, beating analyst estimates. This is generally seen as positive news and could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100